| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MAP kinase activity | 9.70e-14 | 16 | 76 | 7 | GO:0004707 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MAPK14 MAPK12 STK17B PRKAG1 DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 9.47e-07 | 446 | 76 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | protein serine kinase activity | MAPK14 MAPK12 STK17B DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 1.15e-06 | 363 | 76 | 10 | GO:0106310 |
| GeneOntologyMolecularFunction | protein kinase activity | MAPK14 MAPK12 STK17B PRKAG1 PKDCC DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 2.60e-06 | 600 | 76 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | MAPK14 MAPK12 STK17B PRKAG1 PKDCC DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 1.41e-05 | 709 | 76 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | MAPK14 MAPK12 STK17B PRKAG1 PKDCC DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 2.95e-05 | 764 | 76 | 12 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | MAPK14 MAPK12 STK17B PRKAG1 PKDCC DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 TERT MAP3K2 | 4.87e-05 | 938 | 76 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.75e-04 | 37 | 76 | 3 | GO:0045505 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 1.39e-05 | 13 | 77 | 3 | GO:0038133 | |
| GeneOntologyBiologicalProcess | ERBB3 signaling pathway | 1.77e-05 | 14 | 77 | 3 | GO:0038129 | |
| GeneOntologyBiologicalProcess | stress-activated MAPK cascade | 7.97e-05 | 61 | 77 | 4 | GO:0051403 | |
| GeneOntologyBiologicalProcess | regulation of Golgi inheritance | 8.21e-05 | 4 | 77 | 2 | GO:0090170 | |
| GeneOntologyBiologicalProcess | stress-activated protein kinase signaling cascade | 1.29e-04 | 69 | 77 | 4 | GO:0031098 | |
| GeneOntologyBiologicalProcess | developmental growth | SLC39A12 MAPK14 ALMS1 ASPM PKDCC BBS4 FLRT3 MAPK1 MAPK11 UNC79 LEPR SOS1 | 1.33e-04 | 911 | 77 | 12 | GO:0048589 |
| GeneOntologyBiologicalProcess | ERBB2 signaling pathway | 1.37e-04 | 27 | 77 | 3 | GO:0038128 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 1.98e-04 | 77 | 77 | 4 | GO:0007004 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 2.64e-04 | 83 | 77 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | trachea formation | 2.85e-04 | 7 | 77 | 2 | GO:0060440 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage proliferation | 2.85e-04 | 7 | 77 | 2 | GO:0120041 | |
| GeneOntologyBiologicalProcess | positive regulation of cilium assembly | 3.00e-04 | 35 | 77 | 3 | GO:0045724 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 3.60e-04 | 90 | 77 | 4 | GO:0010833 | |
| GeneOntologyBiologicalProcess | regulation of pro-B cell differentiation | 3.80e-04 | 8 | 77 | 2 | GO:2000973 | |
| GeneOntologyBiologicalProcess | regulation of macrophage proliferation | 3.80e-04 | 8 | 77 | 2 | GO:0120040 | |
| GeneOntologyCellularComponent | cytoplasmic dynein complex | 8.85e-05 | 24 | 76 | 3 | GO:0005868 | |
| Domain | MAP_kinase_CS | 7.07e-10 | 12 | 75 | 5 | IPR003527 | |
| Domain | MAPK | 7.07e-10 | 12 | 75 | 5 | PS01351 | |
| Domain | MAPK_p38 | 2.48e-07 | 4 | 75 | 3 | IPR008352 | |
| Domain | Pkinase | MAPK14 MAPK12 STK17B PKDCC DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 3.35e-07 | 381 | 75 | 11 | PF00069 |
| Domain | Kinase-like_dom | MAPK14 MAPK12 STK17B PKDCC DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 SOS1 | 1.56e-06 | 542 | 75 | 12 | IPR011009 |
| Domain | Ser/Thr_kinase_AS | MAPK14 MAPK12 STK17B DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 1.58e-06 | 357 | 75 | 10 | IPR008271 |
| Domain | S_TKc | MAPK14 MAPK12 STK17B DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 1.66e-06 | 359 | 75 | 10 | SM00220 |
| Domain | PROTEIN_KINASE_ST | MAPK14 MAPK12 STK17B DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 1.79e-06 | 362 | 75 | 10 | PS00108 |
| Domain | PROTEIN_KINASE_ATP | MAPK14 MAPK12 STK17B PKDCC DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 2.08e-06 | 459 | 75 | 11 | PS00107 |
| Domain | Protein_kinase_ATP_BS | MAPK14 MAPK12 STK17B DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 2.70e-06 | 379 | 75 | 10 | IPR017441 |
| Domain | Prot_kinase_dom | MAPK14 MAPK12 STK17B PKDCC DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 3.83e-06 | 489 | 75 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MAPK14 MAPK12 STK17B PKDCC DAPK1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 | 4.13e-06 | 493 | 75 | 11 | PS50011 |
| Domain | MAPK_ERK1/2 | 1.59e-05 | 2 | 75 | 2 | IPR008349 | |
| Domain | Dynein_light_1/2_CS | 1.59e-05 | 2 | 75 | 2 | IPR019763 | |
| Domain | MAPK_ERK3/4 | 4.76e-05 | 3 | 75 | 2 | IPR008350 | |
| Domain | Dynein_light | 4.76e-05 | 3 | 75 | 2 | PF01221 | |
| Domain | DYNEIN_LIGHT_1 | 4.76e-05 | 3 | 75 | 2 | PS01239 | |
| Domain | Dynein_light | 4.76e-05 | 3 | 75 | 2 | SM01375 | |
| Domain | Dynein_light_chain_typ-1/2 | 4.76e-05 | 3 | 75 | 2 | IPR001372 | |
| Domain | - | 4.76e-05 | 3 | 75 | 2 | 3.30.740.10 | |
| Domain | GPR107-like | 9.50e-05 | 4 | 75 | 2 | IPR009637 | |
| Domain | Lung_7-TM_R | 9.50e-05 | 4 | 75 | 2 | PF06814 | |
| Domain | PKD_channel | 8.55e-04 | 11 | 75 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 8.55e-04 | 11 | 75 | 2 | IPR013122 | |
| Domain | FERM-adjacent | 1.21e-03 | 13 | 75 | 2 | IPR014847 | |
| Domain | FA | 1.21e-03 | 13 | 75 | 2 | SM01195 | |
| Domain | FA | 1.21e-03 | 13 | 75 | 2 | PF08736 | |
| Domain | IMPORTIN_B_NT | 1.40e-03 | 14 | 75 | 2 | PS50166 | |
| Domain | Ras_G-nucl-exch_fac_CS | 1.40e-03 | 14 | 75 | 2 | IPR019804 | |
| Domain | IBN_N | 1.62e-03 | 15 | 75 | 2 | PF03810 | |
| Domain | IBN_N | 1.84e-03 | 16 | 75 | 2 | SM00913 | |
| Domain | Importin-beta_N | 2.08e-03 | 17 | 75 | 2 | IPR001494 | |
| Domain | RUN | 2.34e-03 | 18 | 75 | 2 | SM00593 | |
| Domain | ARM-type_fold | 2.41e-03 | 339 | 75 | 6 | IPR016024 | |
| Domain | RUN | 2.60e-03 | 19 | 75 | 2 | PS50826 | |
| Domain | RUN | 2.60e-03 | 19 | 75 | 2 | PF02759 | |
| Domain | Run_dom | 2.60e-03 | 19 | 75 | 2 | IPR004012 | |
| Domain | Myosin-like_IQ_dom | 2.60e-03 | 19 | 75 | 2 | IPR027401 | |
| Domain | - | 2.60e-03 | 19 | 75 | 2 | 4.10.270.10 | |
| Domain | - | 2.69e-03 | 69 | 75 | 3 | 1.10.20.10 | |
| Domain | RasGEFN | 2.88e-03 | 20 | 75 | 2 | SM00229 | |
| Domain | RasGEF_N | 3.18e-03 | 21 | 75 | 2 | PF00618 | |
| Domain | Ez/rad/moesin-like | 3.18e-03 | 21 | 75 | 2 | IPR000798 | |
| Domain | Ras-like_Gua-exchang_fac_N | 3.49e-03 | 22 | 75 | 2 | IPR000651 | |
| Domain | RASGEF_NTER | 3.49e-03 | 22 | 75 | 2 | PS50212 | |
| Domain | FERM_CS | 4.15e-03 | 24 | 75 | 2 | IPR019747 | |
| Domain | Histone-fold | 4.54e-03 | 83 | 75 | 3 | IPR009072 | |
| Domain | FERM_C | 4.86e-03 | 26 | 75 | 2 | PF09380 | |
| Domain | RASGEF | 4.86e-03 | 26 | 75 | 2 | PS00720 | |
| Domain | FERM_C | 5.23e-03 | 27 | 75 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 5.23e-03 | 27 | 75 | 2 | IPR018980 | |
| Domain | DEATH | 5.23e-03 | 27 | 75 | 2 | SM00005 | |
| Domain | RASGEF_CAT | 6.02e-03 | 29 | 75 | 2 | PS50009 | |
| Domain | Ubiquitin-rel_dom | 6.43e-03 | 184 | 75 | 4 | IPR029071 | |
| Domain | RasGEF | 6.44e-03 | 30 | 75 | 2 | PF00617 | |
| Domain | - | 6.44e-03 | 30 | 75 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 6.44e-03 | 30 | 75 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 6.44e-03 | 30 | 75 | 2 | IPR001895 | |
| Domain | RasGEF | 6.44e-03 | 30 | 75 | 2 | SM00147 | |
| Domain | PH_dom-like | 7.28e-03 | 426 | 75 | 6 | IPR011993 | |
| Domain | FERM_N | 7.75e-03 | 33 | 75 | 2 | PF09379 | |
| Domain | Death | 7.75e-03 | 33 | 75 | 2 | PF00531 | |
| Domain | FERM_N | 7.75e-03 | 33 | 75 | 2 | IPR018979 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | MAPK14 MAPK12 PRKAG1 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 SOS1 SOS2 | 6.08e-12 | 132 | 59 | 11 | M39338 |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 6.46e-12 | 6 | 59 | 5 | M47766 | |
| Pathway | WP_MAPK_CASCADE | 6.11e-11 | 33 | 59 | 7 | M39594 | |
| Pathway | WP_INSULIN_SIGNALING | MAPK14 MAPK12 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 SOS1 SOS2 | 1.04e-09 | 160 | 59 | 10 | MM15956 |
| Pathway | WP_INSULIN_SIGNALING | MAPK14 MAPK12 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 SOS1 SOS2 | 1.04e-09 | 160 | 59 | 10 | M39482 |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.46e-09 | 81 | 59 | 8 | M13863 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 5.08e-09 | 34 | 59 | 6 | M13881 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 8.60e-09 | 101 | 59 | 8 | M1979 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 2.72e-08 | 76 | 59 | 7 | MM1433 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 3.27e-08 | 78 | 59 | 7 | M39824 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 3.57e-08 | 79 | 59 | 7 | M11816 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 5.38e-08 | 25 | 59 | 5 | M274 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 5.38e-08 | 25 | 59 | 5 | M39384 | |
| Pathway | REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION | 5.70e-08 | 10 | 59 | 4 | M27146 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 5.70e-08 | 10 | 59 | 4 | MM15135 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 5.70e-08 | 10 | 59 | 4 | M13962 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 6.64e-08 | 26 | 59 | 5 | M47565 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 6.64e-08 | 26 | 59 | 5 | MM14716 | |
| Pathway | WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION | 8.13e-08 | 27 | 59 | 5 | M39838 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 9.86e-08 | 28 | 59 | 5 | M39572 | |
| Pathway | WP_MAPK_CASCADE | 9.86e-08 | 28 | 59 | 5 | MM15976 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 1.19e-07 | 29 | 59 | 5 | M39676 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.68e-07 | 14 | 59 | 4 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 2.68e-07 | 14 | 59 | 4 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 2.68e-07 | 14 | 59 | 4 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.68e-07 | 14 | 59 | 4 | M47378 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 2.68e-07 | 14 | 59 | 4 | M47488 | |
| Pathway | SIG_CD40PATHWAYMAP | 2.74e-07 | 34 | 59 | 5 | M12705 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 3.13e-07 | 108 | 59 | 7 | M9904 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47367 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.65e-07 | 15 | 59 | 4 | M47531 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 3.69e-07 | 36 | 59 | 5 | M39908 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 3.71e-07 | 68 | 59 | 6 | M39456 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | TNPO1 MAPK14 MAPK12 ALMS1 DYNLL2 PRKAG1 BBS4 DYNLT2 DYNLL1 MAPK11 | 3.74e-07 | 297 | 59 | 10 | M27050 |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 4.85e-07 | 16 | 59 | 4 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 4.85e-07 | 16 | 59 | 4 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 4.85e-07 | 16 | 59 | 4 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 4.85e-07 | 16 | 59 | 4 | M47804 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 4.85e-07 | 16 | 59 | 4 | M47483 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 5.73e-07 | 118 | 59 | 7 | M39852 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 6.32e-07 | 17 | 59 | 4 | M47376 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 8.94e-07 | 126 | 59 | 7 | M16763 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 1.02e-06 | 19 | 59 | 4 | MM14780 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 1.28e-06 | 20 | 59 | 4 | M12256 | |
| Pathway | BIOCARTA_CREB_PATHWAY | 1.28e-06 | 20 | 59 | 4 | MM1520 | |
| Pathway | BIOCARTA_CREB_PATHWAY | 1.91e-06 | 22 | 59 | 4 | M9070 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 1.91e-06 | 22 | 59 | 4 | M13408 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 2.31e-06 | 23 | 59 | 4 | MM15952 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 2.76e-06 | 24 | 59 | 4 | M27553 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 2.76e-06 | 24 | 59 | 4 | M11190 | |
| Pathway | WP_IL4_SIGNALING | 2.92e-06 | 54 | 59 | 5 | M39720 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 3.01e-06 | 151 | 59 | 7 | M39801 | |
| Pathway | PID_IL2_1PATHWAY | 3.20e-06 | 55 | 59 | 5 | M122 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 3.28e-06 | 25 | 59 | 4 | MM15269 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 3.86e-06 | 26 | 59 | 4 | MM1431 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 4.42e-06 | 160 | 59 | 7 | MM15990 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 4.52e-06 | 27 | 59 | 4 | M7739 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 4.52e-06 | 27 | 59 | 4 | M1718 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 4.52e-06 | 27 | 59 | 4 | MM14779 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.61e-06 | 161 | 59 | 7 | M39770 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 5.26e-06 | 28 | 59 | 4 | MM15132 | |
| Pathway | WP_THERMOGENESIS | 5.70e-06 | 108 | 59 | 6 | M39746 | |
| Pathway | KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY | 5.82e-06 | 62 | 59 | 5 | M15569 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 6.08e-06 | 29 | 59 | 4 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 6.08e-06 | 29 | 59 | 4 | M13494 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK1_TRKA | 6.31e-06 | 63 | 59 | 5 | MM14714 | |
| Pathway | WP_MAPK_SIGNALING | 7.89e-06 | 246 | 59 | 8 | M39597 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 8.00e-06 | 31 | 59 | 4 | M15195 | |
| Pathway | REACTOME_SIGNAL_ATTENUATION | 8.18e-06 | 10 | 59 | 3 | M14236 | |
| Pathway | REACTOME_SIGNAL_ATTENUATION | 8.18e-06 | 10 | 59 | 3 | MM15440 | |
| Pathway | REACTOME_APOPTOSIS | 9.25e-06 | 179 | 59 | 7 | M15303 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 9.89e-06 | 69 | 59 | 5 | M237 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.03e-05 | 33 | 59 | 4 | M39503 | |
| Pathway | PID_MAPK_TRK_PATHWAY | 1.17e-05 | 34 | 59 | 4 | M270 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 1.22e-05 | 72 | 59 | 5 | M3126 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 1.32e-05 | 35 | 59 | 4 | M47379 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 1.43e-05 | 267 | 59 | 8 | M10792 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.49e-05 | 75 | 59 | 5 | M39568 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.49e-05 | 75 | 59 | 5 | MM14652 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 1.49e-05 | 12 | 59 | 3 | MM14657 | |
| Pathway | WP_LEPTIN_SIGNALING | 1.59e-05 | 76 | 59 | 5 | M39491 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 1.59e-05 | 76 | 59 | 5 | M1749 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 1.65e-05 | 37 | 59 | 4 | MM14899 | |
| Pathway | WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS | 1.93e-05 | 13 | 59 | 3 | M39463 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 1.93e-05 | 13 | 59 | 3 | M1441 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.97e-05 | 134 | 59 | 6 | M3574 | |
| Pubmed | 6.68e-16 | 14 | 77 | 7 | 12239168 | ||
| Pubmed | The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. | 5.92e-11 | 13 | 77 | 5 | 17906618 | |
| Pubmed | 1.11e-10 | 5 | 77 | 4 | 24486509 | ||
| Pubmed | RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1. | 7.04e-10 | 20 | 77 | 5 | 32662771 | |
| Pubmed | 7.73e-10 | 7 | 77 | 4 | 15173068 | ||
| Pubmed | F-box Protein βTrCP1 Is a Substrate of Extracellular Signal-regulated Kinase 2. | 1.54e-09 | 8 | 77 | 4 | 34703820 | |
| Pubmed | Nerve growth factor signaling, neuroprotection, and neural repair. | 2.96e-09 | 26 | 77 | 5 | 11520933 | |
| Pubmed | 4.62e-09 | 10 | 77 | 4 | 12223406 | ||
| Pubmed | Novel CDC2-related protein kinases produced in murine hematopoietic stem cells. | 4.62e-09 | 10 | 77 | 4 | 8444355 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 28608568 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20155832 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 25118288 | ||
| Pubmed | Heterogeneous expression of four MAP kinase isoforms in human tissues. | 1.04e-08 | 3 | 77 | 3 | 1319925 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 19259952 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 22522454 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 25592043 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 22579611 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18406464 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18563362 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18358530 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 14714552 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 21448845 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 19543489 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 8290275 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 21085672 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 17268885 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 34709510 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18372245 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 17543571 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 17303382 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 23332156 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 24608673 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 12663671 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18256287 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20738258 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 24619413 | ||
| Pubmed | MAP4K4 is involved in the neuronal development of retinal photoreceptors. | 1.08e-08 | 12 | 77 | 4 | 37290629 | |
| Pubmed | 2.19e-08 | 14 | 77 | 4 | 9687510 | ||
| Pubmed | PRAK, a novel protein kinase regulated by the p38 MAP kinase. | 2.98e-08 | 15 | 77 | 4 | 9628874 | |
| Pubmed | Altered MAPK signaling in progressive deterioration of endothelial function in diabetic mice. | 4.17e-08 | 4 | 77 | 3 | 22933112 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 22158075 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 20610565 | ||
| Pubmed | Role for mitogen-activated protein kinase p38 alpha in lung epithelial branching morphogenesis. | 4.17e-08 | 4 | 77 | 3 | 18177852 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 17463321 | ||
| Pubmed | Acute ethanol exposure inhibits macrophage IL-6 production: role of p38 and ERK1/2 MAPK. | 4.17e-08 | 4 | 77 | 3 | 14634061 | |
| Pubmed | Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. | 4.17e-08 | 4 | 77 | 3 | 15107845 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 11741894 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 27878722 | ||
| Pubmed | LCPTP-MAP kinase interaction: permanent partners or transient associates? | 4.17e-08 | 4 | 77 | 3 | 12413699 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 15249224 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 29475459 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 19418584 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 15537893 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 19936205 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 16814421 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 10066767 | ||
| Pubmed | Essential role for ERK2 mitogen-activated protein kinase in placental development. | 4.17e-08 | 4 | 77 | 3 | 14622137 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 30562644 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 24199952 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 22593579 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 29268268 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 22564616 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 18434625 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 12200131 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 19661066 | ||
| Pubmed | Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. | 4.17e-08 | 4 | 77 | 3 | 9564043 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 10206983 | ||
| Pubmed | The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation. | 4.17e-08 | 4 | 77 | 3 | 28420753 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 21908610 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 21199725 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 21413023 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 26334722 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 19676104 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 31337738 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 19723095 | ||
| Pubmed | Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. | 4.17e-08 | 4 | 77 | 3 | 15616583 | |
| Pubmed | Monitoring protein-protein interactions in mammalian cells by trans-SUMOylation. | 6.64e-08 | 18 | 77 | 4 | 21675959 | |
| Pubmed | 8.39e-08 | 19 | 77 | 4 | 21041952 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 22053946 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 26782637 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 18703508 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 10415025 | ||
| Pubmed | Signalling pathway involving GULP, MAPK and Rac1 for SR-BI-induced phagocytosis of apoptotic cells. | 1.04e-07 | 5 | 77 | 3 | 19122200 | |
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 19199341 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 18487214 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 19801662 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 28938400 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 9211903 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 20729213 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 23088735 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 17464174 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 7478566 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 15632108 | ||
| Pubmed | Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways. | 1.04e-07 | 5 | 77 | 3 | 18080100 | |
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 17921324 | ||
| Pubmed | Sam68 and ERKs regulate leptin-induced expression of OB-Rb mRNA in C2C12 myotubes. | 1.04e-07 | 5 | 77 | 3 | 19524014 | |
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 18061203 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 22733747 | ||
| Pubmed | CCDC134, a novel secretory protein, inhibits activation of ERK and JNK, but not p38 MAPK. | 1.04e-07 | 5 | 77 | 3 | 18087676 | |
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 18949384 | ||
| Interaction | MAPKAPK5 interactions | 1.65e-07 | 66 | 75 | 6 | int:MAPKAPK5 | |
| Interaction | RPS6KA5 interactions | 1.09e-06 | 144 | 75 | 7 | int:RPS6KA5 | |
| Interaction | STAB2 interactions | 4.09e-06 | 9 | 75 | 3 | int:STAB2 | |
| Interaction | DUSP2 interactions | 1.28e-05 | 81 | 75 | 5 | int:DUSP2 | |
| Interaction | BCL2L11 interactions | 1.72e-05 | 86 | 75 | 5 | int:BCL2L11 | |
| Interaction | PTPN5 interactions | 1.82e-05 | 87 | 75 | 5 | int:PTPN5 | |
| Interaction | DUSP16 interactions | 2.86e-05 | 237 | 75 | 7 | int:DUSP16 | |
| Interaction | RPS6KA4 interactions | 3.57e-05 | 100 | 75 | 5 | int:RPS6KA4 | |
| Interaction | MKNK2 interactions | 5.23e-05 | 55 | 75 | 4 | int:MKNK2 | |
| Interaction | SPANXN4 interactions | 5.23e-05 | 55 | 75 | 4 | int:SPANXN4 | |
| Interaction | CLIC5 interactions | 7.25e-05 | 22 | 75 | 3 | int:CLIC5 | |
| Interaction | DUSP4 interactions | 7.87e-05 | 118 | 75 | 5 | int:DUSP4 | |
| Interaction | C4orf36 interactions | 8.16e-05 | 4 | 75 | 2 | int:C4orf36 | |
| Interaction | PTPN7 interactions | 1.01e-04 | 65 | 75 | 4 | int:PTPN7 | |
| Interaction | MBP interactions | 1.07e-04 | 126 | 75 | 5 | int:MBP | |
| Interaction | DPPA3 interactions | 1.14e-04 | 67 | 75 | 4 | int:DPPA3 | |
| Interaction | TACSTD2 interactions | 1.20e-04 | 129 | 75 | 5 | int:TACSTD2 | |
| Interaction | MKNK1 interactions | 1.35e-04 | 70 | 75 | 4 | int:MKNK1 | |
| Interaction | DUSP10 interactions | 1.42e-04 | 71 | 75 | 4 | int:DUSP10 | |
| Interaction | MAPKAPK2 interactions | 1.43e-04 | 134 | 75 | 5 | int:MAPKAPK2 | |
| Interaction | EML4 interactions | 1.59e-04 | 137 | 75 | 5 | int:EML4 | |
| Interaction | ETV1 interactions | 1.69e-04 | 29 | 75 | 3 | int:ETV1 | |
| Interaction | ANKRD20A4P interactions | 2.03e-04 | 6 | 75 | 2 | int:ANKRD20A4P | |
| Interaction | MAP2K4 interactions | 2.37e-04 | 81 | 75 | 4 | int:MAP2K4 | |
| Interaction | FAM83D interactions | 2.48e-04 | 82 | 75 | 4 | int:FAM83D | |
| Interaction | ANKRD20A2P interactions | 2.84e-04 | 7 | 75 | 2 | int:ANKRD20A2P | |
| Interaction | REDIC1 interactions | 2.84e-04 | 7 | 75 | 2 | int:REDIC1 | |
| Interaction | CDC25C interactions | 2.91e-04 | 156 | 75 | 5 | int:CDC25C | |
| Interaction | MAPK12 interactions | 2.98e-04 | 86 | 75 | 4 | int:MAPK12 | |
| Interaction | SUPT20H interactions | 3.12e-04 | 87 | 75 | 4 | int:SUPT20H | |
| Interaction | GMFB interactions | 3.24e-04 | 36 | 75 | 3 | int:GMFB | |
| Interaction | MAP2K3 interactions | 3.45e-04 | 251 | 75 | 6 | int:MAP2K3 | |
| Interaction | PIPSL interactions | 3.53e-04 | 252 | 75 | 6 | int:PIPSL | |
| Interaction | BCL2 interactions | 3.56e-04 | 163 | 75 | 5 | int:BCL2 | |
| Interaction | DCTN2 interactions | 3.58e-04 | 356 | 75 | 7 | int:DCTN2 | |
| Interaction | ELK4 interactions | 3.86e-04 | 92 | 75 | 4 | int:ELK4 | |
| Cytoband | 15q21 | 1.51e-04 | 11 | 77 | 2 | 15q21 | |
| GeneFamily | Mitogen-activated protein kinases | 5.89e-15 | 13 | 61 | 7 | 651 | |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 1.11e-04 | 5 | 61 | 2 | 1021 | |
| GeneFamily | 7TM orphan receptors | 1.67e-04 | 6 | 61 | 2 | 310 | |
| GeneFamily | Dyneins, cytoplasmic | 8.53e-04 | 13 | 61 | 2 | 538 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.65e-03 | 18 | 61 | 2 | 596 | |
| GeneFamily | Transient receptor potential cation channels | 4.00e-03 | 28 | 61 | 2 | 249 | |
| GeneFamily | Proteasome | 9.25e-03 | 43 | 61 | 2 | 690 | |
| GeneFamily | WD repeat domain containing | 1.18e-02 | 262 | 61 | 4 | 362 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.24e-02 | 50 | 61 | 2 | 1293 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 166 | 77 | 5 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-05 | 176 | 77 | 5 | dbc4f64cd39b229f2355ca1d0215cc7f6a767dce | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 179 | 77 | 5 | 2c3abd646d2c8992e8ff76a824eab5beba8ba4c6 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 179 | 77 | 5 | 6eb84fe9691ad40127b2d1f1c672428333c8fab4 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 190 | 77 | 5 | ac2eb1e51459d187095152e0cd41ae54c1025c6f | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 190 | 77 | 5 | 6010f16378f2d9cde37c7e7db6a7d9666edaddcc | |
| Drug | SB202474 | 1.29e-14 | 14 | 77 | 7 | CID000005162 | |
| Drug | oridonin | 1.08e-11 | 54 | 77 | 8 | CID000034378 | |
| Drug | procymidone | 6.52e-11 | 40 | 77 | 7 | CID000036242 | |
| Drug | piribedil | 9.39e-11 | 42 | 77 | 7 | CID000004850 | |
| Drug | celiprolol | 2.16e-10 | 47 | 77 | 7 | CID000002663 | |
| Drug | DENSPM | 2.52e-10 | 48 | 77 | 7 | CID000004282 | |
| Drug | trapidil | 8.84e-10 | 57 | 77 | 7 | CID000005531 | |
| Drug | AC1L1CFC | 1.00e-09 | 58 | 77 | 7 | CID000001874 | |
| Drug | CEP-1347 | 1.13e-09 | 59 | 77 | 7 | CID000133005 | |
| Drug | dipropionamide | 1.80e-09 | 6 | 77 | 4 | CID000138646 | |
| Drug | dimethyl selenone | 1.80e-09 | 6 | 77 | 4 | CID000176413 | |
| Drug | lysosphingomyelin | 3.58e-09 | 160 | 77 | 9 | CID000005263 | |
| Drug | SR144528 | 3.87e-09 | 70 | 77 | 7 | CID003081355 | |
| Drug | Wkymvm | 4.28e-09 | 71 | 77 | 7 | CID000457933 | |
| Drug | potassium phosphate | 7.80e-09 | 121 | 77 | 8 | CID000024450 | |
| Drug | thunberginol B | 8.38e-09 | 8 | 77 | 4 | CID005473310 | |
| Drug | Clorocruoro Hem | 8.88e-09 | 123 | 77 | 8 | CID003518809 | |
| Drug | p38 MAP kinase inhibitor | 1.37e-08 | 130 | 77 | 8 | CID000004665 | |
| Drug | ebselen | 1.46e-08 | 131 | 77 | 8 | CID000003194 | |
| Drug | lapatinib | 1.66e-08 | 86 | 77 | 7 | CID000208908 | |
| Drug | arsenate | 1.85e-08 | 135 | 77 | 8 | CID000000233 | |
| Drug | ethyl acetate | 2.08e-08 | 137 | 77 | 8 | CID000008857 | |
| Drug | alpha-ketoisovalerate | 2.11e-08 | 89 | 77 | 7 | CID000000049 | |
| Drug | C070379 | 2.40e-08 | 199 | 77 | 9 | CID003034747 | |
| Drug | AC1NOLIT | 2.50e-08 | 10 | 77 | 4 | CID005090286 | |
| Drug | 0-to | 2.60e-08 | 141 | 77 | 8 | CID000002051 | |
| Drug | Ro 31 | 2.60e-08 | 141 | 77 | 8 | CID000214797 | |
| Drug | DEAC | 3.12e-08 | 55 | 77 | 6 | CID000007277 | |
| Drug | Dethiocoenzyme A | 3.60e-08 | 147 | 77 | 8 | CID000003002 | |
| Drug | nemorosone | 3.92e-08 | 11 | 77 | 4 | CID000637105 | |
| Drug | CdCl2 | 4.14e-08 | 98 | 77 | 7 | CID000024947 | |
| Drug | L001226 | 5.17e-08 | 30 | 77 | 5 | CID004373102 | |
| Drug | K-Cl | MAPK14 MAPK12 DYNLL2 TACR3 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 TERT RYR3 MYO5C SOS2 | 5.28e-08 | 567 | 77 | 13 | CID000004873 |
| Drug | BAPTA-AM | MAPK14 MAPK12 HACD3 STK17B MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 RYR3 | 5.48e-08 | 293 | 77 | 10 | CID000002293 |
| Drug | MDL-28842 | 5.86e-08 | 12 | 77 | 4 | CID006441200 | |
| Drug | AICAR monophosphate | 8.04e-08 | 163 | 77 | 8 | CID000000200 | |
| Drug | N-(4-aminobutyl)-1-naphthalenesulfonamide | 8.45e-08 | 13 | 77 | 4 | CID000005679 | |
| Drug | LBH589 | 8.66e-08 | 109 | 77 | 7 | CID006918837 | |
| Drug | ERK inhibitor | 9.25e-08 | 166 | 77 | 8 | CID001249835 | |
| Drug | 1pzj | 9.69e-08 | 167 | 77 | 8 | CID000447976 | |
| Drug | 9,12,15-octadecatrienoic acid | 9.69e-08 | 167 | 77 | 8 | CID000000860 | |
| Drug | AC1NDP1U | 1.25e-07 | 115 | 77 | 7 | CID004629339 | |
| Drug | hydroxybutyrate | 1.25e-07 | 115 | 77 | 7 | CID000010413 | |
| Drug | pyridinyl imidazole | 1.35e-07 | 36 | 77 | 5 | CID000005171 | |
| Drug | BAPTA | MAPK14 MAPK12 SACS DYNLL2 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 RYR3 | 1.40e-07 | 324 | 77 | 10 | CID000104751 |
| Drug | Ac2-26 | 1.48e-07 | 4 | 77 | 3 | CID000568638 | |
| Drug | bovine serum albumin-corticosterone conjugate | 1.48e-07 | 4 | 77 | 3 | ctd:C439264 | |
| Drug | corticosterone-21-hemisuccinate | 1.48e-07 | 4 | 77 | 3 | ctd:C067957 | |
| Drug | NSC-68458 | 1.48e-07 | 4 | 77 | 3 | CID000249771 | |
| Drug | MMP-2 Inhibitor I | 1.60e-07 | 15 | 77 | 4 | CID000004220 | |
| Drug | SB 239063 | 2.13e-07 | 16 | 77 | 4 | CID000005166 | |
| Drug | apocynin | 2.22e-07 | 186 | 77 | 8 | CID000002214 | |
| Drug | nickel hydroxide | 2.28e-07 | 259 | 77 | 9 | CID000025500 | |
| Drug | Go6983 | 2.33e-07 | 40 | 77 | 5 | CID000003499 | |
| Drug | 1c88 | 2.34e-07 | 126 | 77 | 7 | CID000444766 | |
| Drug | Go6976 | 2.61e-07 | 190 | 77 | 8 | CID000003501 | |
| Drug | SF6847 | 2.64e-07 | 41 | 77 | 5 | CID000005614 | |
| Drug | AEBSF | 2.72e-07 | 191 | 77 | 8 | CID000001701 | |
| Drug | Ambotz208527-57-5 | 2.78e-07 | 17 | 77 | 4 | CID010258704 | |
| Drug | kazinol B | 2.78e-07 | 17 | 77 | 4 | CID000480869 | |
| Drug | NSC407322 | 3.06e-07 | 131 | 77 | 7 | CID000003977 | |
| Drug | SB202190 | 3.57e-07 | 134 | 77 | 7 | CID005353940 | |
| Drug | Nitrosomethylurethane | 3.70e-07 | 5 | 77 | 3 | ctd:D009605 | |
| Drug | AC1Q5V5T | 3.75e-07 | 135 | 77 | 7 | CID000004701 | |
| Drug | dehydroepiandrosterone sulfate | 4.02e-07 | 277 | 77 | 9 | CID000005244 | |
| Drug | geranylgeranyl pyrophosphate | 4.57e-07 | 139 | 77 | 7 | CID000000735 | |
| Drug | C11102 | 4.65e-07 | 86 | 77 | 6 | CID000443069 | |
| Drug | AC1L45LU | 4.66e-07 | 205 | 77 | 8 | CID000151069 | |
| Drug | n-sulfo-2-aminotricarballylate | 5.62e-07 | 20 | 77 | 4 | CID000135808 | |
| Drug | AC1L1H7K | 5.81e-07 | 144 | 77 | 7 | CID000004010 | |
| Drug | vasopressin | MAPK14 MAPK12 ALMS1 PSMA2 TACR3 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 | 7.31e-07 | 388 | 77 | 10 | CID011979316 |
| Drug | vanadium | 7.32e-07 | 149 | 77 | 7 | CID000023990 | |
| Drug | methyl(acetoxymethyl)nitrosamine | 7.38e-07 | 6 | 77 | 3 | ctd:C014659 | |
| Drug | tolyltriazole | 7.38e-07 | 6 | 77 | 3 | CID000025902 | |
| Drug | arachidonic acid trifluoromethyl ketone | 8.75e-07 | 153 | 77 | 7 | CID000002224 | |
| Drug | inhibitor of p38 kinase | 9.80e-07 | 53 | 77 | 5 | CID000027933 | |
| Drug | sorafenib | 1.09e-06 | 158 | 77 | 7 | CID000216239 | |
| Drug | SKF86002 | 1.22e-06 | 24 | 77 | 4 | CID000005228 | |
| Drug | Sorbitol | 1.22e-06 | 24 | 77 | 4 | ctd:D013012 | |
| Drug | octadec-9-en-1-amine | 1.22e-06 | 24 | 77 | 4 | CID000008219 | |
| Drug | baicalein | 1.28e-06 | 162 | 77 | 7 | CID005281605 | |
| Drug | Cp-38 | 1.29e-06 | 7 | 77 | 3 | CID006918286 | |
| Drug | satratoxin H | 1.29e-06 | 7 | 77 | 3 | CID000434380 | |
| Drug | 2,2',4,6-tetrachlorobiphenyl | 1.29e-06 | 7 | 77 | 3 | CID000044163 | |
| Drug | CID6325568 | 1.29e-06 | 7 | 77 | 3 | CID006325568 | |
| Drug | poly(methyl methacrylate) (PMMA | 1.29e-06 | 56 | 77 | 5 | CID003032549 | |
| Drug | UV-C | 1.34e-06 | 163 | 77 | 7 | CID005289542 | |
| Drug | AC1L1GZB | 1.57e-06 | 167 | 77 | 7 | CID000003908 | |
| Drug | ciglitazone | 1.70e-06 | 169 | 77 | 7 | CID000002750 | |
| Drug | AC1NSK9Q | 1.71e-06 | 26 | 77 | 4 | CID005311233 | |
| Drug | U0126 | MAPK14 MAPK12 DYNLL2 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 MAP3K2 SOS1 | 1.85e-06 | 430 | 77 | 10 | CID000005637 |
| Drug | calphostin C | SLC8A2 MAPK14 MAPK12 DYNLL2 TACR3 MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 | 1.88e-06 | 431 | 77 | 10 | CID000002533 |
| Drug | AC1L1KS5 | 1.90e-06 | 334 | 77 | 9 | CID000005631 | |
| Drug | AC1L1KC5 | SLC8A2 MAPK14 MAPK12 SACS STK17B MAPK1 MAPK3 MAPK4 MAPK6 MAPK11 RYR3 | 2.00e-06 | 541 | 77 | 11 | CID000005428 |
| Drug | Z-D-CH2DCB | 2.06e-06 | 8 | 77 | 3 | CID009911778 | |
| Drug | ML3403 | 2.06e-06 | 8 | 77 | 3 | CID006419739 | |
| Drug | phytosphingosine | 2.06e-06 | 8 | 77 | 3 | ctd:C012491 | |
| Drug | CPS 11 | 2.06e-06 | 8 | 77 | 3 | ctd:C494620 | |
| Drug | phenolate | 2.33e-06 | 254 | 77 | 8 | CID000000996 | |
| Drug | SB220025 | 2.69e-06 | 29 | 77 | 4 | CID000005164 | |
| Disease | neurodevelopmental disorder with eye movement abnormalities and ataxia (implicated_via_orthology) | 6.20e-06 | 2 | 74 | 2 | DOID:0081275 (implicated_via_orthology) | |
| Disease | Astrocytosis | 1.00e-05 | 17 | 74 | 3 | C3887640 | |
| Disease | Gliosis | 1.00e-05 | 17 | 74 | 3 | C0017639 | |
| Disease | hepatocellular clear cell carcinoma (is_marker_for) | 1.86e-05 | 3 | 74 | 2 | DOID:5016 (is_marker_for) | |
| Disease | Cardiomyopathies | 1.94e-05 | 130 | 74 | 5 | C0878544 | |
| Disease | Cardiomyopathies, Primary | 2.78e-05 | 69 | 74 | 4 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 2.78e-05 | 69 | 74 | 4 | C0036529 | |
| Disease | mitogen-activated protein kinase 12 measurement | 3.71e-05 | 4 | 74 | 2 | EFO_0020576 | |
| Disease | Subfertility, Female | 4.74e-05 | 28 | 74 | 3 | C0341869 | |
| Disease | Sterility, Postpartum | 4.74e-05 | 28 | 74 | 3 | C0038279 | |
| Disease | Female sterility | 4.74e-05 | 28 | 74 | 3 | C0917730 | |
| Disease | Female infertility | 4.74e-05 | 28 | 74 | 3 | C0021361 | |
| Disease | Cholestasis, Extrahepatic | 7.13e-05 | 32 | 74 | 3 | C0005398 | |
| Disease | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | 9.25e-05 | 6 | 74 | 2 | C1866282 | |
| Disease | Streptococcal pneumonia | 9.25e-05 | 6 | 74 | 2 | C0155862 | |
| Disease | age at menarche | 1.21e-04 | 594 | 74 | 8 | EFO_0004703 | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 1.29e-04 | 7 | 74 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.44e-04 | 105 | 74 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | ureteral obstruction (implicated_via_orthology) | 2.21e-04 | 9 | 74 | 2 | DOID:5199 (implicated_via_orthology) | |
| Disease | endometrial adenocarcinoma (is_marker_for) | 3.36e-04 | 11 | 74 | 2 | DOID:2870 (is_marker_for) | |
| Disease | Trigeminal Neuralgia | 4.03e-04 | 12 | 74 | 2 | C0040997 | |
| Disease | chronic kidney disease (implicated_via_orthology) | 4.03e-04 | 12 | 74 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | Secondary Trigeminal Neuralgia | 4.03e-04 | 12 | 74 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 4.03e-04 | 12 | 74 | 2 | C0393786 | |
| Disease | Myeloproliferative disease | 4.03e-04 | 12 | 74 | 2 | C0027022 | |
| Disease | Brain Ischemia | 4.68e-04 | 60 | 74 | 3 | C0007786 | |
| Disease | Cerebral Ischemia | 4.68e-04 | 60 | 74 | 3 | C0917798 | |
| Disease | Lung Neoplasms | 5.47e-04 | 265 | 74 | 5 | C0024121 | |
| Disease | gastric ulcer (implicated_via_orthology) | 5.54e-04 | 14 | 74 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of lung | 5.56e-04 | 266 | 74 | 5 | C0242379 | |
| Disease | Hypogonadotropic hypogonadism | 6.38e-04 | 15 | 74 | 2 | C0271623 | |
| Disease | Primary hypogonadism | 6.38e-04 | 15 | 74 | 2 | C0948896 | |
| Disease | Hypogonadism, Isolated Hypogonadotropic | 6.38e-04 | 15 | 74 | 2 | C3489396 | |
| Disease | serum albumin measurement | 7.11e-04 | 592 | 74 | 7 | EFO_0004535 | |
| Disease | Hypogonadism | 7.28e-04 | 16 | 74 | 2 | C0020619 | |
| Disease | Hypertrophy | 9.25e-04 | 18 | 74 | 2 | C0020564 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 9.25e-04 | 18 | 74 | 2 | C0342384 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 1.03e-03 | 19 | 74 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 1.03e-03 | 19 | 74 | 2 | C0587248 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 1.03e-03 | 19 | 74 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 1.03e-03 | 19 | 74 | 2 | C1275081 | |
| Disease | Dystonia | 1.33e-03 | 86 | 74 | 3 | C0013421 | |
| Disease | LEOPARD Syndrome | 1.39e-03 | 22 | 74 | 2 | C0175704 | |
| Disease | Septicemia | 1.65e-03 | 24 | 74 | 2 | C0036690 | |
| Disease | Sepsis | 1.65e-03 | 24 | 74 | 2 | C0243026 | |
| Disease | Severe Sepsis | 1.65e-03 | 24 | 74 | 2 | C1719672 | |
| Disease | Head Neoplasms | 1.65e-03 | 24 | 74 | 2 | C0018675 | |
| Disease | Upper Aerodigestive Tract Neoplasms | 1.65e-03 | 24 | 74 | 2 | C0887900 | |
| Disease | Pyemia | 1.65e-03 | 24 | 74 | 2 | C0034189 | |
| Disease | Noonan Syndrome | 1.65e-03 | 24 | 74 | 2 | C0028326 | |
| Disease | Cancer of Head | 1.65e-03 | 24 | 74 | 2 | C0751177 | |
| Disease | Neck Neoplasms | 1.79e-03 | 25 | 74 | 2 | C0027533 | |
| Disease | Cancer of Neck | 1.79e-03 | 25 | 74 | 2 | C0746787 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.94e-03 | 26 | 74 | 2 | DOID:234 (is_implicated_in) | |
| Disease | Kallmann Syndrome | 1.94e-03 | 26 | 74 | 2 | C0162809 | |
| Disease | neutrophil count, eosinophil count | 2.05e-03 | 213 | 74 | 4 | EFO_0004833, EFO_0004842 | |
| Disease | obesity (implicated_via_orthology) | 2.12e-03 | 215 | 74 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | Myeloid Leukemia, Chronic | 2.41e-03 | 29 | 74 | 2 | C0023473 | |
| Disease | neutrophil count, basophil count | 2.46e-03 | 224 | 74 | 4 | EFO_0004833, EFO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KQILNGVYYLHSLQI | 121 | P53355 | |
| FINILHRYYKSALVQ | 91 | P54619 | |
| LYLQLGIYQKAFEHL | 211 | Q96RK4 | |
| ALIIAGFVLYLYKHR | 3421 | Q7Z408 | |
| RQSYLIGLTLLHYLN | 631 | Q86UK0 | |
| NLLKVERIYLYHNSL | 81 | Q9NZU0 | |
| YSHREKLLVFYQQAL | 811 | Q8TCU4 | |
| IQFQRYNKLRHSVIY | 2231 | Q8IZT6 | |
| YNKLRHSVIYIQAIF | 2236 | Q8IZT6 | |
| YLLQRYLGHFLQEKL | 16 | Q96BY7 | |
| VVYYITHLLKGALLF | 331 | Q5VW38 | |
| INLAKLKLFRHYYVL | 486 | Q5VW38 | |
| VIRYLTFFHNYNILI | 401 | Q9GZU1 | |
| YQILRGLKYIHSANV | 131 | P28482 | |
| HVQFLVYQLLRGLKY | 126 | Q15759 | |
| FLGLYINFRHLYKQR | 336 | Q9P035 | |
| YQLLRGLKYIHSANV | 131 | P31152 | |
| HVQFLIYQILRGLKY | 126 | Q16539 | |
| IYQILRGLKYIHSAD | 131 | Q16539 | |
| KHFIYFYLGQVAILL | 71 | P63167 | |
| LFMYQLLRGLKYIHS | 131 | Q16659 | |
| KNLLHERIVQYYGCL | 411 | Q9Y2U5 | |
| LFRNYNYKVHLLYVL | 151 | P48357 | |
| DHICYFLYQILRGLK | 141 | P27361 | |
| FLYQILRGLKYIHSA | 146 | P27361 | |
| AHQINIGYYLTLLFL | 126 | Q86Y13 | |
| YKDILLLGNNYVIHR | 191 | Q14541 | |
| ILYVYPKAFVQLRHL | 96 | Q7Z2Q7 | |
| YKQVGYLVLLHSLDR | 2611 | Q6V1P9 | |
| YLLYLQIKRDIFHGR | 126 | A2A2Y4 | |
| YLVFLQIKRDLYHGR | 111 | Q7Z6J6 | |
| VFKLRNHILYLIENY | 56 | Q9H5Z1 | |
| GYALQLHQLQVLYKA | 76 | Q02318 | |
| LLEFQILLYSQHYQR | 306 | Q6IQ26 | |
| VKIHITGLRNDYYLN | 221 | Q86Y33 | |
| VQRVSLLLLYYIIHQ | 111 | Q504Y0 | |
| LKRFGNAVILLYIQH | 4076 | Q9NZJ4 | |
| YRPVYFQLVDVLLHK | 386 | O94829 | |
| AIVYYLIQKFHSRAL | 31 | Q9GZY4 | |
| KHFIYFYLGQVAILL | 71 | Q96FJ2 | |
| RLFQENLGLLHKYYV | 111 | Q8IWE5 | |
| FVRLYKAGLLYRNHQ | 261 | Q5ST30 | |
| LYPLFVYLHLNLVQN | 96 | O75529 | |
| DLLKYYHQVTRAVLG | 156 | Q9Y6J9 | |
| IVTYALGIYHLNLFI | 66 | O15258 | |
| ILKLAGNYVFNIRHY | 141 | Q07890 | |
| RLLAYVIFHLQYINP | 256 | A8MYB1 | |
| EKVLHLYRSGQYLQN | 386 | Q504Y2 | |
| LQTIALLGYLKHYRN | 216 | P28370 | |
| VAGIGFYQHLLLYIQ | 116 | Q9UPR3 | |
| RYFRYILKQDHQILG | 416 | Q15573 | |
| FQLLVDYIYHGTVKL | 96 | Q9NVX7 | |
| VYNIFRILLYHAIKY | 916 | Q8NFP9 | |
| YYIAHLLKGALLFIT | 331 | Q9NPR9 | |
| IRLIKQILEGVYYLH | 136 | O94768 | |
| QLKIYTRLATIYHNF | 1276 | Q8TE82 | |
| VQLANFYLVPLHYRL | 141 | P39210 | |
| TDYLLVVNLHYGIRL | 236 | Q8IZU2 | |
| HIYFILTAIYQQLNR | 316 | P29371 | |
| ILKLVGNYVRNIRHY | 141 | Q07889 | |
| VRIAHLVQYFFYKNL | 871 | Q8NB49 | |
| RRLNHYVLYKAVQGF | 106 | O43242 | |
| EIYQTKLLHYLARNF | 4396 | Q15413 | |
| KYFRYNSLLIRHQII | 231 | Q6ZNG0 | |
| THGRYVLVIYENLLK | 131 | P52849 | |
| LVHRARKLAQQYYLV | 86 | P25787 | |
| GLSKLQELVRYHIYN | 566 | Q9NY15 | |
| YQLIEYLHKNLRVEG | 126 | Q14CB8 | |
| YYNVQIFLLLGQLLK | 336 | Q9NZM6 | |
| YQHKNLLILYDAIGT | 541 | Q92973 | |
| YFYILASVILNVHLQ | 66 | Q96HG1 | |
| HLIRGQSVIKLYIIY | 186 | Q6NXT6 | |
| FLGIIRLYDYLQQLH | 336 | Q9H347 | |
| IYKILLLQAYRFHAC | 1001 | O14746 | |
| ILLQYLILFQYLKGQ | 321 | Q96FV9 | |
| NTVKRHLYVLLGYDQ | 1306 | Q9P2D8 | |
| GYHRYKFIIKVLFIQ | 141 | Q8IZS6 | |
| QFLVYQMLKGLRYIH | 131 | P53778 | |
| LEQLVGIANYYALLH | 331 | Q9UPR5 | |
| FVRKNYILNLRYHLP | 781 | Q8N1T3 | |
| KHCRGYLVRSLYQLI | 816 | Q9NQX4 |